Universal Newborn Screening for Severe Combined Immunodeficiency (SCID)

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Severe combined immunodeficiency (SCID) is a primary immunodeficiency characterized by a lack of functional T-lymphocytes.
• Early detection is critical for preventing life-threatening infections and enabling timely hematopoietic stem cell transplantation.
• Newborn screening aims to identify SCID before clinical symptoms manifest.

Purpose of the Study:

• To review the development and outcomes of universal newborn screening for SCID using T-cell receptor excision circles (TREC).
• To discuss the implementation of TREC screening in dried blood spots (DBS).
• To highlight ongoing challenges in SCID screening programs.

Main Methods:

• Review of literature on TREC assay development and validation for SCID screening.
• Analysis of outcomes from implemented newborn screening programs for SCID.
• Discussion of logistical and clinical challenges in SCID screening and follow-up.

Main Results:

• Universal newborn screening for SCID using TREC assays in DBS is established nationwide in the US.
• TREC screening enables early identification of infants with potential SCID.
• Programmatic outcomes and challenges are continuously being evaluated.

Conclusions:

• Newborn screening for SCID via TREC analysis has become a critical public health initiative.
• Continued efforts are needed to optimize screening protocols and address implementation hurdles.
• Early diagnosis through TREC screening facilitates prompt treatment and improves outcomes for SCID patients.